361 results
Aspirin-free antiplatelet regimens after PCI: when is it best to stop aspirin and who could ultimately benefit?
18 Oct 2019
Over the past year, an abundance of clinical evidence has emerged addressing the conceptually appealing and theoretically justified concept of dropping aspirin, rather than the P2Y12 antagonist, as part of antiplatelet regimens after percutaneous coronary intervention (PCI).
Authors :
2nd edition of the Percutaneous Cardiac Interventions Textbook
09 Oct 2019
Editors M. Sabaté and S. Brugaletta share how the additional live cases, videos and media content provide crystal clear tips and tricks on new procedures.
Ticagrelor with or without aspirin in high-risk patients after PCI
07 Oct 2019
The TWILIGHT trial was designed to test the hypothesis that in patients undergoing PCI who are at high risk for ischemic or hemorrhagic complications and who have completed a 3-month course of DAPT with ticagrelor plus aspirin, continued treatment with ticagrelor monotherapy would be superior to ticagrelor...
Reviewer
Editor's picks: impactful articles in interventional cardiology
01 Oct 2019
Struggling to keep up with the mass of scientific information in interventional cardiology? On this page you will find a selection of recent articles published in major journals in the field - use it to guide your reading!
Preventive cardiology: what the interventional cardiologist needs to know in 2019
19 Sep 2019
Risk and aspirin, blood pressure, cholesterol, diabetes: read this article written by J.W. McEvoy and D. Mylotte
Authors :
2nd online edition - Tips and Tricks of new techniques beyond stenting: Benefit from a FREE access to the most consulted chapter in 2019!
20 Jan 2020
Enjoy free access to the most consulted chapter in 2019 on "The use of non-hyperaemic indices of stenosis severity in clinical practice" by A. McInerney, N. Gonzalo, H. Mejía-Rentería, J. Davies, J. Escaned.
SASSICAIA trial - Comparison of loading strategies with DAPT in patients undergoing PCI
03 Sep 2019
Live from the ESC Congress 2019: Julinda Mehilli from Munich shares with us the results of the SASSICAIA randomised trial on comparison of loading strategies with antiplatelet drugs in patients undergoing elective coronary intervention.
Author
SYNTAXES - Ten-year survival after coronary artery bypass grafting vs PCI: the SYNTAX Extended Survival study
03 Sep 2019
At the ESC Congress 2019 in Paris, Daniel Johannes presented the results of the SYNTAX Extended Survival study. Read the report by Mirvat Alasnag.
Author
New innovative solutions for serious needs: check it out!
28 Aug 2019 – From EuroPCR 2019
Consult this session to discover new innovative solutions for serious needs, such as the Ultraseal device, the V-LAP system, and more!
Same-day discharge after elective percutaneous coronary intervention: Insights from the British Cardiovascular Intervention Society
06 Aug 2019
The aim of this study was to evaluate national temporal trends in same-day discharge (SDD) and compare clinical outcomes with those among patients admitted for overnight stay undergoing elective PCI for stable angina.
Reviewer
